Description
A selective β2-AR agonist (EC50s = 97.7 and 2,725 nM for human β2- and β1-ARs, respectively); completely reverses acetylcholine-induced bronchoconstriction without cardiovascular side effects in guinea pigs; exhibits dose-dependent bronchoprotection in a beagle model of acetylcholine-induced bronchoconstriction,
Formal name: 6-hydroxy-8-[(1R)-1-hydroxy-2-[[2-(4-methoxyphenyl)-1,1-dimethylethyl]amino]ethyl]-2H-1,4-benzoxazin-3(4H)-one
Synonyms: BI-1744
Molecular weight: 386.4
CAS: 868049-49-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area